Deeks SG - Search Results

1

Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates.

Bangsberg DR, Porco TC, Kagay C, Charlebois ED, Deeks SG, Guzman D, Clark R, Moss A. Bangsberg DR, et al. Among authors: deeks sg. J Infect Dis. 2004 Jul 1;190(1):162-5. doi: 10.1086/420790. Epub 2004 Jun 9. J Infect Dis. 2004. PMID: 15195256

2

HIV-1 protease inhibitors. A review for clinicians.

Deeks SG, Smith M, Holodniy M, Kahn JO. Deeks SG, et al. JAMA. 1997 Jan 8;277(2):145-53. JAMA. 1997. PMID: 8990341 Review.

3

Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days.

Deeks SG, Coleman RL, White R, Pachl C, Schambelan M, Chernoff DN, Feinberg MB. Deeks SG, et al. J Infect Dis. 1997 Aug;176(2):514-7. doi: 10.1086/517278. J Infect Dis. 1997. PMID: 9237721

4

HIV-1 protease inhibitors.

Deeks SG, Volberding PA. Deeks SG, et al. AIDS Clin Rev. 1997-1998:145-85. doi: 10.1001/jama.1997.03540260059037. AIDS Clin Rev. 1997. PMID: 9305448 Review. No abstract available.

5

The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.

Deeks SG, Collier A, Lalezari J, Pavia A, Rodrigue D, Drew WL, Toole J, Jaffe HS, Mulato AS, Lamy PD, Li W, Cherrington JM, Hellmann N, Kahn J. Deeks SG, et al. J Infect Dis. 1997 Dec;176(6):1517-23. doi: 10.1086/514150. J Infect Dis. 1997. PMID: 9395363 Clinical Trial.

6

Practical issues regarding the use of antiretroviral therapy for HIV infection.

Deeks SG. Deeks SG. West J Med. 1998 Feb;168(2):133-9. West J Med. 1998. PMID: 9499754 Free PMC article. Review.

7

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure.

Deeks SG, Grant RM, Beatty GW, Horton C, Detmer J, Eastman S. Deeks SG, et al. AIDS. 1998 Jul 9;12(10):F97-102. doi: 10.1097/00002030-199810000-00002. AIDS. 1998. PMID: 9677159

8

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.

Deeks SG, Hellmann NS, Grant RM, Parkin NT, Petropoulos CJ, Becker M, Symonds W, Chesney M, Volberding PA. Deeks SG, et al. J Infect Dis. 1999 Jun;179(6):1375-81. doi: 10.1086/314775. J Infect Dis. 1999. PMID: 10228057 Clinical Trial.

9

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

10

Failure of HIV-1 protease inhibitors to fully suppress viral replication. Implications for salvage therapy.

Deeks SG. Deeks SG. Adv Exp Med Biol. 1999;458:175-82. doi: 10.1007/978-1-4615-4743-3_17. Adv Exp Med Biol. 1999. PMID: 10549390 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters